Rigorous clinical trials like SOLSTICE can help us evaluate oral medications that may be just as effective for patients with diabetes while overcoming these limitations." Elecoglipron was developed specifically for the treatment of type 2 diabetes
Insurance coverage is plan-dependent
Watch for: Increased hunger Frequent cravings Larger meal portions Reduced exercise Emotional eating Gradual increases on the scale Small gains are often easier to address than major weight regain
In AWARD-1, the once-weekly injectable GLP-1 agonist demonstrated superior glycemic control compared with twice-daily exenatide (Byetta) in type 2 diabetic patients not adequately controlled with full-dose metformin and pioglitazone
If youre experiencing significant side effects, talk to your prescriber about dose holds, slower titration, or switching therapieschanging the medication plan is the practical route, not trying to force faster drug removal
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review